OD6 Metals Limited (ASX: OD6) has launched a metallurgical diamond core drilling campaign at its 100%-owned Splinter Rock Rare Earth Project in Western Australia. This work is focused on Inside Centre, the deposit that has consistently delivered standout metallurgy and supports near-term development studies.

E79 Gold Mines Limited (ASX: E79) has signed a binding agreement to acquire 90% of Cue Metals Pty Ltd, securing the rights to the Cue Gold Project (~70 km²) in the Day Dawn Goldfield, immediately south of Westgold’s high-grade Great Fingall operation (historic 1.2 Moz @ 19.2 g/t Au). The company has also received binding commitments for a $3.0 million placement at A$0.021/share (two tranches) to accelerate exploration.

E79 Gold Mines (ASX: E79) has returned all final assays from reconnaissance air-core (AC) drilling at the T14 South prospect within the Laverton South Gold Project, delineating two distinct gold anomalies beneath a regional paleochannel and flagging follow-up work at depth. The Company also completed an additional 15 AC holes northwest of the Lighthorse discovery, with assays pending.

Race Oncology Limited (ASX: RAC) has announced a major scientific breakthrough that could reshape its commercial and clinical trajectory. The company has discovered that bisantrene – a clinically validated cancer drug – exists as three photoisomers, with only the (E,E)-bisantrene form possessing significant anticancer activity. This discovery has enabled Race to file three new patent applications, potentially providing composition of matter intellectual property (IP) protecti

Pursuit Minerals Ltd (ASX: PUR) has signed a binding agreement to acquire 100% of Andara Mining Pty Ltd, securing rights over the Sascha–Marcelina Gold-Silver Project in the Deseado Massif, Santa Cruz, Argentina—one of the world’s premier epithermal belts. In parallel, the Company has received firm commitments of A$4.04 million to accelerate high-impact drilling across multiple walk-up targets.

Proteomics International Laboratories Ltd (ASX: PIQ) has been granted ISO 15189 certification for its Australian laboratory operations – a key milestone that cements its role as a leader in precision diagnostics. This certification validates the company’s systems, processes, and quality management, ensuring accurate and dependable clinical results.

OpenLearning Limited (ASX: OLL) has signed a five-year, usage-based SaaS agreement with Systems Plus College Foundation (SPCF), a comprehensive non-sectarian education provider in the Philippines. The partnership will see SPCF deploy OpenLearning’s AI-powered learning management system across all levels – from grade school to graduate programs.

Mesoblast Limited (ASX: MSB; Nasdaq: MESO) has highlighted the successful commercial launch of its flagship therapy, Ryoncil® (remestemcel-L-rknd), at two major global healthcare conferences — Morgan Stanley and Cantor Fitzgerald’s Annual Global Healthcare events in New York. This milestone underscores Mesoblast’s position as a global leader in allogeneic cellular medicines for inflammatory diseases.

In this latest episode of Coffee with Samso, we return to the UWA Club in Crawley to meet with Cliff Fitzhenry, CEO of DY6 Metals Ltd (ASX: DY6). This conversation cuts through the technical noise to examine what could become a globally significant rutile and titanium discovery in Africa.

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) has presented important data from its ATH434-201 Phase 2 clinical trial at the 150th Annual Meeting of the American Neurological Association (ANA) in Baltimore, USA. The trial focused on Multiple System Atrophy (MSA), a rare and rapidly progressive neurodegenerative disease. These results mark a significant milestone for Alterity as it moves closer to providing the first disease-modifying therapy for MSA.

Great Northern Minerals Ltd (ASX: GNM) has announced a significant expansion of its Catalyst Ridge REE–Antimony Project in the Mountain Pass District, California (Figure 1). The move marks a step-change in the Company’s U.S. footprint, adding new ground in one of the world’s most strategic rare earth corridors.

Golden Dragon Mining Ltd (ASX: GDR) is set to list on the ASX on 14 October 2025, following a fully subscribed IPO raising A$5 million at $0.20 per share. With a post-money market cap of A$8.89M and an enterprise value of just ~A$3.7M, GDR offers investors an attractive entry point into a multi-project gold explorer positioned in one of Western Australia’s most productive gold provinces.